 |
Articles: Neuro/Psych pharmacology |
Prior Articles
250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
The Lancet Neurology, 09/10/09
Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine
Neuropsychopharmacology, 09/10/09 Pharmacogenetic Testing for Guiding de novo Phenprocoumon Therapy in Stroke Patients
Cerebrovascular Diseases, 09/10/09 Treatment of Progressive Stroke with Tirofiban - Experience in 35 Patients
Cerebrovascular Diseases, 09/10/09 Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition
Neuropsychopharmacology, 09/10/09 Pharmacogenomics of antidepressant drugs
Pharmacology & Therapeutics, 09/10/09 Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria
Neuropsychopharmacology, 09/10/09 The clinical efficacy and abuse potential of combination buprenorphine–naloxone in the treatment of opioid dependence
Expert Opinion in Pharmacotherapy, 09/09/09 Lacosamide: what can be expected from the next new antiepileptic drug
Epilepsy Currents, 09/09/09 The effects of pre-emptive analgesia with bupivacaine on acute post-laminectomy pain
Archives of Orthopaedic and Trauma Surgery, 09/09/09 Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol
International Journal of Neuropsychopharmacology, 09/09/09 Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls
International Journal of Neuropsychopharmacology, 09/09/09 Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine
Cephalalgia, 09/08/09 Donepezil treatment in severe Alzheimers disease: a pooled analysis of three clinical trials
Current Medical Research and Opinion, 09/08/09 Ceftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking
Biological Psychiatry, 09/08/09 Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Journal of Clinical Oncology, 09/04/09 Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
Therapeutic Advances in Neurological Disorders, 09/04/09 BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans
European Neuropsychopharmacology, 09/04/09 Antipsychotic drug actions on gene modulation and signaling mechanisms
Pharmacology & Therapeutics, 09/04/09 Population-Based Study of Pseudoprogression after Chemoradiotherapy in GBM
Canadian Journal of Neurological Sciences, 09/03/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
